Answers are grounded in this paper and cite their sources.
Tremblay and colleagues asked whether patients receiving either routine anticoagulation or antiplatelet therapy for existing conditions prior to becoming ill with COVID-19 have different outcomes from patients receiving neither therapy. After matching for existing comorbidities, this retrospective observational study finds no evidence for an effect of prediagnosis anticoagulation on mortality.
No takes yet. Share an insight, caveat, or question.
Tremblay et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: